Cite

HARVARD Citation

    Gomez-Roca, C. et al. (n.d.). 443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. Annals of oncology. p. . [Online]. 
  
Back to record